Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Q4 2022 Results Conference Call February 22, 2023 1:00 PM ET

Company Participants

Lukas Hartwich - SVP, Finance

Rick Matros - CEO, President and Chair

Talya Nevo-Hacohen - Chief Investment Officer, Treasurer, and EVP

Michael Costa - Chief Financial Officer

Conference Call Participants

Avery Tiras - Citi

Juan Sanabria - BMO Capital Markets

Vikram Malhotra - Mizuho

Rich Anderson - SMBC

Joshua Dennerlein - Bank of America

Steven Valiquette - Barclays

Tayo Okusanya - Credit Suisse

John Pawlowski - Green Street Advisors

Operator

Good day, everyone. My name is Rob, and I will be your conference operator today. At this time, I'd like to welcome everyone to the Sabra Fourth Quarter 2022 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session [Operator Instructions]. I would like to turn the call over to Lukas Hartwich, Senior Vice President, Finance. Please go ahead, Mr. Hartwich.

Lukas Hartwich

Thank you, and good morning. Before we begin, I want to remind you that we will be making forward-looking statements in our comments and in response to your questions concerning our expectations regarding our future financial position and results of operations, including our expectations regarding our tenants and operators and our expectations regarding our acquisition, disposition and investment plans. These forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including the risks listed in our Form 10-K for the year ended December 31, 2022, as well as in our earnings press release, included as Exhibit 99.1 to the Form 8-K we furnished to the SEC yesterday. We undertake no obligation to update our forward-looking statements to reflect subsequent events or circumstances, and you should not assume later in the quarter that the comments we make today are still valid. In addition, references will be made during this call to non-GAAP financial results. Investors are encouraged to review these non-GAAP financial measures as well as the explanation and reconciliation of these measures to the comparable GAAP results included on the financials page of the Investors section of our Web site at sabrahealth.com. Our Form 10-K, earnings release and supplement can also be accessed in the Investors section of our Web site. And with that, let me turn the call over to Rick Matros, CEO, President and Chair of Sabra Health Care REIT.